Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $82,502.92 +1.05%
Ethereum $2,481.88 +0.30%
BNB $741.70 +1.10%
Optimism $0.13 +6.40%
Arbitrum $0.18 +4.85%
Solana $109.00 -0.89%
Polygon $0.22 +2.77%
Cosmos $2.02 +16.32%
Avalanche $10.29 +2.01%

Bitcoin $82,502.92 +1.05%
Ethereum $2,481.88 +0.30%
BNB $741.70 +1.10%
Optimism $0.13 +6.40%
Arbitrum $0.18 +4.85%
Solana $109.00 -0.89%
Polygon $0.22 +2.77%
Cosmos $2.02 +16.32%
Avalanche $10.29 +2.01%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed